MEGAN MEDICARE LIMITED

Company Registration Number:
08493644 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2024

Period of accounts

Start date: 01 May 2023

End date: 30 April 2024

MEGAN MEDICARE LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

MEGAN MEDICARE LIMITED

Company Information

for the Period Ended 30 April 2024




Director: Mavis EGAN
Registered office: 4
Hubert Road
Rainham
England
RM13 8AB
Company Registration Number: 08493644 (England and Wales)

MEGAN MEDICARE LIMITED

Directors' Report Period Ended 30 April 2024

The directors present their report with the financial statements of the company for the period ended 30 April 2024

Principal Activities

Other human health activities

Directors

The director(s) shown below were appointed to the company during the period
Mavis EGAN
01 May 2023

This report was approved by the board of directors on 29 January 2025
And Signed On Behalf Of The Board By:

Name: Mavis EGAN
Status: Director

MEGAN MEDICARE LIMITED

Profit and Loss Account

for the Period Ended 30 April 2024


2024
£

2023
£
Turnover 23,758 -
Cost of Materials ( 20,920 ) -
Profit or (Loss) for Period 2,838 -

MEGAN MEDICARE LIMITED

Balance sheet

As at 30 April 2024


2024
£

2023
£
Fixed Assets: 10,895 11,895
Current assets: 4,500 3,525
Prepayments and accrued income: 762 762
Creditors: amounts falling due within one year: ( 3,006 ) ( 3,006 )
Net current assets (liabilities): 2,256 1,281
Total assets less current liabilities: 13,151 13,176
Total net assets (liabilities): 13,151 13,176
Capital and reserves: 13,151 13,176

MEGAN MEDICARE LIMITED

Balance sheet continued

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 January 2025
And Signed On Behalf Of The Board By:

Name: Mavis EGAN
Status: Director

The notes form part of these financial statements

MEGAN MEDICARE LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Employee Information

    Average number of employees: 1

MEGAN MEDICARE LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Off balance sheet disclosure

    No